 |
市場調査レポート
商品コード
968294
世界の生物学的データの視覚化市場規模調査：技術別、用途別、プラットフォーム別、最終用途別、および地域別予測（2020～2027年）Global Biological Data Visualization Market Size study, by Technique, by Application, by Platform, by End-Use and Regional Forecasts 2020-2027 |
||||||
| 世界の生物学的データの視覚化市場規模調査：技術別、用途別、プラットフォーム別、最終用途別、および地域別予測（2020～2027年） |
|
出版日: 2020年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
|
世界の生物学的データの視覚化の市場規模は2019年に約7億4,190万米ドルとなりました。同市場は、2020年から2027年の予測期間にわたって9.6％を超える健全な成長率で成長すると予想されています。
生物学的データの視覚化には、次世代シーケンシング（NGS）テクノロジーの進歩、化学成分のネットワークと相互作用をよりよく理解するための新しいシーケンシングマシン、および遺伝子調節、アラインメント、高分子構造、系統発生論、システム生物学、顕微鏡検査、分散、共分散などの関係性を分析することなどが含まれます。
病院や診療所、製薬企業やバイオテクノロジー企業、学術研究機関など、さまざまな最終用途で使用されています。生物学的データのサイズの大きさと複雑さというビッグデータの懸念に対してAIの利用が増加したことに加えて、仮想現実環境と高度な分析ツールの採用が増えたことが、予測期間中の市場の成長を担う要因です。
さらに、高度な技術を提供するための製薬およびヘルスケアセクターへの研究開発費の増加は、この市場に豊富な需要を生み出すでしょう。たとえば、Statistaによると、製薬業界における世界の研究開発費は2012年に1,360億米ドルだったものが、2019年には1,860億米ドルに増加しました。また、2026年には製薬業界における世界の研究開発に2,330億米ドルにのぼると見込まれています。ただし、データ管理のコンピュータによる一貫性が確保できないことや、ユーザーインターフェイスに関連する問題が、予測期間中の世界の生物データの資格化市場の成長を妨げる主な要因です。
当レポートでは、世界の生物学的データの視覚化市場について調査し、市場の概要とともに、技術別、用途別、プラットフォーム別、最終用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。Title:
Global Biological Data Visualization Market Size study, by Technique (Microscopy, Magnetic Resonance Imaging, Sequencing, X-ray Crystallography and Others), by Application (Cell and Organism Imaging, Structural Biology and Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, and Evolution and Systems Biology), by Platform (Windows, Mac OS, Linux and Others), by End-Use (Academic Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other) and Regional Forecasts 2020-2027.
Global Biological Data Visualization Market is valued approximately at USD 741.9 million in 2019 and is anticipated to grow with a healthy growth rate of more than 9.6% over the forecast period 2020-2027. Biological Data Visualization includes advances in Next-Generation Sequencing (NGS) technologies and new sequencing machines for better understanding of networks and interactions of chemical components, as well as the analysis of relations such as gene regulation, alignments, macromolecular structures, phylogenies, systems biology, microscopy, variance, co-variance etc. It is used in various end use application including hospitals & clinics, pharmaceutical & biotechnology companies, academic research and others. The rising adoption of virtual reality environment and advanced analytical tool along with the growing utilization of AI for big data concerns with large size and complexity of biological data are the few factors responsible for growth of the market over the forecast period. Furthermore, the rising R&D spending on pharmaceutical and healthcare sector in order to provide advanced technologies will create a lucrative demand for this market. For instance: as per Statista, the global research and development spending in pharmaceutical industry was USD 136 billion in 2012 and has been risen to USD 186 billion in 2019 . Also, it is expected to rise to USD 233 billion spending of global research and development in pharmaceutical industry in 2026. However, the unavailability of computational consistency for data management and problems related to user interface is the major factor restraining the growth of global Biological Data Visualization market during the forecast period.
The regional analysis of global Biological Data Visualization market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the high R&D investment in the region positively impacts the advancement of these sectors, accelerating the demand for analysis software to visualize the biological data generated or required for these fields. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.
Major market player included in this report are:
3M Company
Thermo Fisher Scientific, Inc.
Genialis, Inc.
Agilent Technologies
QIAGEN
Carl Zeiss AG
Oxford Instruments
Becton, Dickinson and Company (BD)
Genedata AG
Olympus Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technique:
Microscopy
Magnetic Resonance Imaging
Sequencing
X-ray Crystallography
Others
By Application:
Cell and Organism Imaging
Structural Biology and Molecular Modeling
Genomic Analysis
Alignments, Phylogeny, and Evolution
Systems Biology
By Platform:
Windows
Mac OS
Linux
Others
By End Use:
Academic Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027
Target Audience of the Global Biological Data Visualization Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
比較リスト
